Prostate Cancer - Results from #25900

Abiraterone acetate: A novel therapeutic option in hormone-refractory prostate cancer - Abstract May 16, 2012

What management for the asymptomatic men carriers of BRCA1 or 2 mutation? Results of a survey in the French oncogenetic centers - Abstract May 16, 2012

Current status of salvage robot-assisted laparoscopic prostatectomy for radiorecurrent prostate cancer - Abstract May 16, 2012

Comparison of health-related quality-of-life outcomes for African-American and Caucasian-American men after radical prostatectomy - Abstract May 16, 2012

Technical refinement and learning curve for attenuating neurapraxia during robotic-assisted radical prostatectomy to improve sexual function - Abstract May 16, 2012

Optimizing the care of patients with advanced prostate cancer in the UK: Current challenges and future opportunities - Abstract May 16, 2012

Lower testosterone levels with luteinizing hormone-releasing hormone agonist therapy than with surgical castration: New insights attained by mass spectrometry - Abstract May 15, 2012

A critical assessment of post-prostatectomy prostate specific antigen doubling time acceleration-is it stable? - Abstract May 15, 2012

Clinical and demographic characteristics associated with prostate cancer progression in patients on active surveillance - Abstract May 15, 2012

Radical prostatectomy outcome in men 65 years old or older with low risk prostate cancer - Abstract May 15, 2012

A contemporary update on pathology reporting for prostate cancer: Biopsy and radical prostatectomy specimens - Abstract May 15, 2012

Classifying prostate cancer malignancy by quantitative histomorphometry - Abstract May 15, 2012

International variation in prostate cancer incidence and mortality rates - Abstract May 15, 2012

Introducing parametric fusion PET/MRI of primary prostate cancer - Abstract May 15, 2012

Prediction of functional outcomes after nerve-sparing radical prostatectomy: Results of conditional survival analyses - Abstract May 15, 2012

Salvage cryoablation for locally recurrent prostate cancer following primary radiotherapy - Abstract May 15, 2012

Racial/Ethnic differences in treatment discussed, preferred, and received for prostate cancer in a tri-ethnic population - Abstract May 14, 2012

Is sampling transitional zone in patients who had prior negative prostate biopsy necessary? - Abstract May 14, 2012

Pathological findings at radical prostatectomy in patients initially managed by active surveillance: A comparative analysis - Abstract May 14, 2012

Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer - Abstract May 14, 2012

Page 1296 of 1437